A. Aouba, S. Georgin-Lavialle, C. Pagnoux, N. M. Silva, A. Renand, et al., “Rationale and Efficacy of Interleukin-1 Targeting in Erdheim-Chester Disease,” Blood, Vol. 116, No. 20, 2012, pp. 4070-4076. doi:10.1182/blood-2010-04-279240

has been cited by the following article:

• TITLE: Erdheim-Chester Disease with Right Atrial Tumor and “Temporal Arteritis”

  AUTHORS: Joseph Skalski, William D. Edwards, Eric L. Matteson

  KEYWORDS: Erdheim-Chester Disease; Temporal Arteritis; Giant Cell Arteritis

  JOURNAL NAME: Open Journal of Rheumatology and Autoimmune Diseases, Vol.2 No.3, August 21, 2012

  ABSTRACT: Erdheim-Chester disease is an unusual syndrome characterized by non-Langerhans cell histiocytosis which can mimic rheumatologic diseases. We report a case of Erdheim-Chester masquerading as giant cell arteritis, which was success-fully managed with anakinra as anti IL-1 therapy.